betamethasone
-
Corticosteroids with low glucocorticoid activity as a potential therapeutic strategy for post‐COVID‐19 [ME/CFS], 2025, Nakajima et al
Corticosteroids with low glucocorticoid activity as a potential therapeutic strategy for post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome in patients with bipolar affective disorder: A case report Kan Nakajima, Nobutaka Ayani, Teruyuki Matsuoka, Kenya Kasahara, Yoshiyuki...- forestglip
- Thread
- betamethasone bipolar corticosteroids hydrocortisone long covid me/cfs prednisolone
- Replies: 1
- Forum: ME/CFS research